Status:
UNKNOWN
A Registered Cohort Study of Immune-Mediated Neuropathies
Lead Sponsor:
First Affiliated Hospital of Fujian Medical University
Collaborating Sponsors:
Beijing Tiantan Hospital
Conditions:
Chronic Inflammatory Demyelinating Polyneuropathy
Eligibility:
All Genders
18+ years
Brief Summary
This study will provide further insights into the natural course of the disease about Immune-Mediated Neuropathies including clinical features，progression, related antibody spectrum and drug treatment...
Eligibility Criteria
Inclusion
- \- 1. Outpatient or inpatient 2. Meet the diagnostic criteria of various inflammatory peripheral neuropathy. 3. Voluntary participation and informed consent signed by the applicant or his/her family.
- 4\. Age 18 or above
Exclusion
- Severe complications
- Poor prognosis (\<1 year survival)
- Severe mental disorder and inability to cooperate with the examination.
- Age less than 18
Key Trial Info
Start Date :
February 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 19 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04292834
Start Date
February 29 2020
End Date
January 19 2025
Last Update
December 30 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
2
Department of Neurology,First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China, 350005